Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CURE-H Pylori
NCT07344506Phase 4Recruiting
- Sponsor
- Dow University of Health Sciences
- Start
- May 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexlansoprazole, lansoprazole, vonoprazan in Helicobacter pylori infection, sponsored by Dow University of Health Sciences. Started May 2025; status: recruiting.
02
Drugs
dexlansoprazolelansoprazolevonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07344506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07344506.